Method for preparing 4-chloro-5-(4-tolyl)-1H-imidazole-2-formonitrile
By using thionyl chloride and a reducing agent in a fluid medium, the problems of harsh reaction conditions and low yield in the preparation of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile in the prior art have been solved, realizing an efficient, economical and environmentally friendly preparation process with significantly improved yield and purity.
Patent Information
- Application Number
- CN202480055864.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2023-09-29
- Filing Date
- 2024-08-31
- Publication Date
- 2026-05-15
AI Technical Summary
Existing techniques for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile suffer from problems such as harsh reaction conditions, long reaction time, low yield, the need for expensive or toxic reagents, and complex operation.
A method was adopted to react the compound of formula II with a chlorinating agent in a fluid medium, followed by a reaction with a reducing agent, using thionyl chloride as the chlorinating agent, and carried out in the presence of an organic base, to prepare 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile by one or two steps.
It achieves an efficient, economical, and environmentally friendly preparation process, increasing the yield to 60% to 80% and the purity to 90% to 96%, making it suitable for commercial-scale production.
Smart Images

Figure SMS_3 
Figure SMS_7 
Figure QLYQS_1
Abstract
Description
Technical Field
[0001] This disclosure relates to a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile. Background Technology
[0002] The background information described below relates to this disclosure but is not necessarily prior art.
[0003] 4-Chloro-5-(4-Tolyl)-1H-imidazol-2-carboxynitrile is a key intermediate in the synthesis of cyazofamid. The structure of 4-chloro-5-(4-Tolyl)-1H-imidazol-2-carboxynitrile is as follows: .
[0004] Cyazofamid is an important fungicide. Its chemical name is 4-chloro-2-cyano-N,N-dimethyl-5-(4-tolyl)-1H-imidazol-1-sulfonamide. The structure of cyazofamid is: .
[0005] Typically, the preparation of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is carried out in DMF in the presence of sodium bisulfite, followed by chlorination with N-chlorosuccinimide (NCS). N-chlorosuccinimide (NCS) is expensive, and the succinimide byproducts formed during the reaction require cumbersome post-treatment to remove them.
[0006] Furthermore, conventional methods for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile have drawbacks, such as harsh reaction conditions, long reaction times, low yields, the need for toxic, expensive, or unavailable reagents, impracticality, and operational limitations during synthesis. Therefore, conventional methods cannot provide an effective solution for the synthesis of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile.
[0007] Therefore, there is a need for a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile that overcomes the above-mentioned disadvantages or at least provides a useful alternative.
[0008] Purpose of the invention At least one embodiment described herein satisfies some of the objectives of this disclosure as follows: One object of this disclosure is to improve one or more problems of the prior art, or at least to provide a useful alternative.
[0009] Another object of this disclosure is to provide a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile.
[0010] Another object of this disclosure is to provide a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile with relatively higher purity and higher yield.
[0011] Another object of this disclosure is to provide a simple, efficient and cost-effective method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile.
[0012] Another object of this disclosure is to provide an environmentally friendly and commercially scalable method for the preparation of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile.
[0013] Other objects and advantages of this disclosure will become more apparent from the following description, which is not intended to limit the scope of this disclosure. Summary of the Invention
[0014] This disclosure relates to a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile. The method comprises reacting a compound of formula II with a chlorinating agent in a fluid medium, followed by a reaction with a reducing agent, optionally in the presence of an organic base.
[0015] In a first embodiment of this disclosure, the method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile includes the following steps: a. In a fluid medium, under stirring, at a first predetermined temperature, the compound of formula II is reacted with a chlorinating agent for a first predetermined time period to obtain a mixture of the compound of formula III and the compound of formula I;
[0016] b. In a fluid medium, under stirring, at a second predetermined temperature, a mixture of compound III and compound I is reduced using a reducing agent for a second predetermined time period to obtain 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (Formula I). .
[0017] In a second embodiment of this disclosure, a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile includes: reacting a compound of formula II with a chlorinating agent in a fluid medium under stirring at a first predetermined temperature for a first predetermined time period to obtain a reaction mixture; subsequently adjusting the pH of the reaction mixture with a base, then adding a reducing agent and stirring at a second predetermined temperature for a second predetermined time period to obtain 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile (Formula I). .
[0018] In embodiments of this disclosure, the chlorinating agent is thionyl chloride.
[0019] In embodiments of this disclosure, the molar ratio of the compound of formula II to the chlorinating agent is in the range of 1:1.5 to 1:5.
[0020] In embodiments of this disclosure, the fluid medium is selected from the group consisting of dimethylformamide (DMF), dimethylacetamide, sulfolane, dimethyl sulfoxide, N-methylpyrrolidone, acetonitrile, benzonitrile, and combinations thereof.
[0021] In embodiments of this disclosure, the first predetermined temperature is in the range of 0°C to 60°C.
[0022] In embodiments of this disclosure, the first predetermined time period is in the range of 2 to 10 hours.
[0023] In the second embodiment of this disclosure, the base is selected from organic bases and inorganic bases.
[0024] The organic bases are selected from the group consisting of triethylamine, diisopropylammonia, pyridine, piperidine, and morpholine.
[0025] Inorganic bases are selected from the group consisting of ammonia, potassium carbonate, sodium carbonate, potassium hydroxide, and sodium hydroxide.
[0026] In embodiments of this disclosure, the reducing agent is selected from the group consisting of metal salts containing sulfur derivatives, sodium metabisulfite, sodium bisulfite, sodium sulfite, potassium bisulfite, potassium metabisulfite, potassium sulfite, potassium dithionite, sodium dithionite, and combinations thereof.
[0027] In embodiments of this disclosure, the molar ratio of the compound of formula II to the reducing agent is in the range of 1:0.1 to 1:1.
[0028] In embodiments of this disclosure, the molar ratio of the compound of formula II to the base is in the range of 1:1 to 1:3.
[0029] In embodiments of this disclosure, the second predetermined temperature is in the range of 40°C to 150°C.
[0030] In embodiments of this disclosure, the second predetermined time period is in the range of 1 hour to 15 hours.
[0031] In embodiments of this disclosure, the yield of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile is in the range of 60% to 80%.
[0032] 4-Chloro-5-(4-Tolyl)-1H-Imidazol-2-carboxynitrile was prepared according to the method of this disclosure.
[0033] In embodiments of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile is greater than 90%.
[0034] In embodiments of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile is in the range of 90% to 96%. Detailed Implementation
[0035] This disclosure relates to a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile.
[0036] This document now describes embodiments of the present disclosure. Embodiments are provided to thoroughly and completely convey the scope of this disclosure to those skilled in the art. Numerous details relating to particular components and methods are set forth to provide a complete understanding of embodiments of the present disclosure. It will be apparent to those skilled in the art that the details provided in the embodiments should not be construed as limiting the scope of the disclosure. In some embodiments, well-known methods, well-known apparatus structures, and well-known techniques are not described in detail.
[0037] The terminology used in this disclosure is for the purpose of explaining particular embodiments only and should not be construed as limiting the scope of this disclosure. As used herein, the forms “a,” “an,” and “the” may also be intended to include plural forms unless the context explicitly suggests otherwise. The terms “comprises,” “comprising,” “including,” and “having” are open-ended transitional phrases that describe the presence of the stated features, integers, steps, operations, elements, modules, units, and / or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and / or combinations thereof. The specific order of steps disclosed in the methods and processes of this disclosure should not be construed as requiring them to be performed in the order stated or shown. It should also be understood that additional or alternative steps may be employed.
[0038] As used herein, the term “and / or” includes any and all combinations of one or more of the listed relevant elements.
[0039] The terms first, second, third, etc., should not be construed as limiting the scope of this disclosure, as these terms may be used only to distinguish one element, component, region, layer, or part from another. Terms such as first, second, third, etc., as used herein do not imply a particular order or sequence unless expressly implied in this disclosure.
[0040] Typically, the preparation of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is carried out in DMF in the presence of sodium bisulfite, followed by chlorination with N-chlorosuccinimide (NCS). N-chlorosuccinimide (NCS) is expensive, and the succinimide byproducts formed during the reaction require cumbersome post-treatment to remove them.
[0041] Furthermore, conventional methods for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile have drawbacks, such as harsh reaction conditions, long reaction times, low yields, the need for toxic, expensive, or unavailable reagents, impracticality, and operational limitations during synthesis. Therefore, conventional methods cannot provide an effective solution for the synthesis of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile.
[0042] This disclosure provides an improved method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile. The structure of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile is shown in Formula I: .
[0043] The method disclosed herein is simple, efficient, environmentally friendly, and economical, and improves the yield and purity of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile.
[0044] According to this disclosure, a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (Formula I) comprises reacting a compound of Formula II with a chlorinating agent in a fluid medium, followed by a reaction with a reducing agent, optionally in the presence of an organic base.
[0045] In a first embodiment, this disclosure provides a two-step method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile (Formula I).
[0046] In a second embodiment, this disclosure provides a one-step method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (Formula I).
[0047] According to a first embodiment of this disclosure, a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (Formula I) includes the following steps: a) In a fluid medium, under stirring, at a first predetermined temperature, the compound of formula II is reacted with a chlorinating agent for a first predetermined time period to obtain a mixture of the compound of formula III and the compound of formula I; and
[0048] b) In a fluid medium, under stirring, at a second predetermined temperature, a mixture of compound III and compound I is reduced using a reducing agent for a second predetermined time period to obtain 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (Formula I). .
[0049] According to the first embodiment of this disclosure, the chlorinating agent is thionyl chloride.
[0050] According to a first embodiment of this disclosure, the molar ratio of the compound of formula II to the chlorinating agent is in the range of 1:1.5 to 1:5. In an exemplary embodiment of this disclosure, the molar ratio of the compound of formula II to the chlorinating agent is 1:2.5.
[0051] According to a first embodiment of this disclosure, the fluid medium is selected from the group consisting of dimethylformamide (DMF), dimethylacetamide, sulfolane, dimethyl sulfoxide, N-methylpyrrolidone, acetonitrile, benzonitrile, and combinations thereof. In an exemplary embodiment of this disclosure, the fluid medium is selected from the group consisting of dimethylformamide (DMF).
[0052] According to a first embodiment of this disclosure, the first predetermined temperature is in the range of 0°C to 60°C. In an exemplary embodiment of this disclosure, the first predetermined temperature is 30°C.
[0053] According to a first embodiment of this disclosure, the first predetermined time period is in the range of 2 to 10 hours. In an exemplary embodiment of this disclosure, the first predetermined time period is 4 hours.
[0054] According to a first embodiment of this disclosure, the reducing agent is selected from the group consisting of metal salts containing sulfur derivatives, sodium metabisulfite, sodium bisulfite, sodium sulfite, potassium bisulfite, potassium metabisulfite, potassium sulfite, potassium dithionite, sodium dithionite, and combinations thereof. In an exemplary embodiment of this disclosure, the reducing agent is sodium metabisulfite.
[0055] According to a first embodiment of this disclosure, the second predetermined temperature is in the range of 40°C to 150°C. In a preferred embodiment of this disclosure, the second predetermined temperature is 80°C to 100°C. In an exemplary embodiment of this disclosure, the second predetermined temperature is 90°C.
[0056] According to a first embodiment of this disclosure, the second predetermined time period is in the range of 1 hour to 15 hours. In a preferred embodiment of this disclosure, the second predetermined time period is 4 hours to 8 hours. In an exemplary embodiment of this disclosure, the second predetermined time period is 6 hours.
[0057] 4-Chloro-5-(4-Tolyl)-1H-Imidazol-2-carboxynitrile was prepared according to the method of this disclosure.
[0058] According to embodiments of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile is greater than 90%.
[0059] According to embodiments of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is in the range of 90% to 96%. In an exemplary embodiment of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is 94%.
[0060] According to a first embodiment of this disclosure, the yield of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is in the range of 60% to 80%. In an exemplary embodiment of this disclosure, the yield of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is 64.29%.
[0061] According to a second embodiment of this disclosure, a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile (Formula I) includes: reacting a compound of Formula II with a chlorinating agent in a fluid medium under stirring at a first predetermined temperature for a first predetermined time period to obtain a reaction mixture; subsequently adjusting the pH of the reaction mixture with a base, then adding a reducing agent, and stirring at a second predetermined temperature for a second predetermined time period to obtain 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylonitrile (Formula I). .
[0062] According to the second embodiment of this disclosure, the chlorinating agent is thionyl chloride.
[0063] According to embodiments of this disclosure, multiple reactions occur during the conversion of compound II to compound I, namely deprotection, dehydration, reduction, and chlorination using a chlorinating agent. In particular, the use of thionyl chloride in this method causes these multiple reactions, such as deprotection, dehydration, reduction, and chlorination, to occur in a single step, thereby making the method efficient and economical.
[0064] The method disclosed herein avoids the need to use multiple reagents to carry out multiple reactions.
[0065] According to a second embodiment of this disclosure, the molar ratio of the compound of formula II to the chlorinating agent is in the range of 1:1.5 to 1:5. In an exemplary embodiment of this disclosure, the molar ratio of the compound of formula II to the chlorinating agent is 1:2.5.
[0066] According to a second embodiment of this disclosure, the fluid medium is selected from the group consisting of dimethylformamide (DMF), dimethylacetamide, sulfolane, dimethyl sulfoxide, N-methylpyrrolidone, acetonitrile, benzonitrile, and combinations thereof. In an exemplary embodiment of this disclosure, the fluid medium is selected from the group consisting of dimethylformamide (DMF).
[0067] According to a second embodiment of this disclosure, the first predetermined temperature is in the range of 0°C to 60°C. In an exemplary embodiment of this disclosure, the first predetermined temperature is 30°C.
[0068] According to a second embodiment of this disclosure, the first predetermined time period is in the range of 2 to 10 hours. In an exemplary embodiment of this disclosure, the first predetermined time period is 4 hours.
[0069] According to the second embodiment of this disclosure, the alkali is selected from organic alkali and inorganic alkali.
[0070] The organic base is selected from the group consisting of triethylamine, diisopropylamine, pyridine, piperidine, and morpholine. In an exemplary embodiment of this disclosure, the organic base is triethylamine.
[0071] Inorganic bases are selected from the group consisting of ammonia, potassium carbonate, sodium carbonate, potassium hydroxide, and sodium hydroxide.
[0072] According to a second embodiment of this disclosure, the reducing agent is selected from the group consisting of metal salts containing sulfur derivatives, sodium metabisulfite, sodium bisulfite, sodium sulfite, potassium bisulfite, potassium metabisulfite, potassium sulfite, potassium dithionite, sodium dithionite, and combinations thereof. In an exemplary embodiment of this disclosure, the reducing agent is sodium metabisulfite.
[0073] According to a second embodiment of this disclosure, the molar ratio of the compound of formula II to the reducing agent is in the range of 1:0.1 to 1:1. In an exemplary embodiment of this disclosure, the molar ratio of the compound of formula II to the reducing agent is 1:0.33.
[0074] According to a second embodiment of this disclosure, the molar ratio of the compound of formula II to the base is in the range of 1:1 to 1:3. In an exemplary embodiment of this disclosure, the molar ratio of the compound of formula II to the base is 1:1.33.
[0075] According to a second embodiment of this disclosure, the second predetermined temperature is in the range of 40°C to 150°C. In an exemplary embodiment of this disclosure, the second predetermined temperature is 50°C.
[0076] According to a second embodiment of this disclosure, the second predetermined time period is in the range of 1 hour to 15 hours. In an exemplary embodiment of this disclosure, the second predetermined time period is 2 hours.
[0077] According to a second embodiment of this disclosure, the yield of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is in the range of 60% to 80%. In an exemplary embodiment of this disclosure, the yield of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is 77.15%.
[0078] 4-Chloro-5-(4-Tolyl)-1H-Imidazol-2-carboxynitrile was prepared according to the method of this disclosure.
[0079] According to embodiments of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile is greater than 90%.
[0080] According to embodiments of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is in the range of 90% to 96%. In an exemplary embodiment of this disclosure, the purity of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile is 93%.
[0081] This disclosure provides a simple, environmentally friendly and economical method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxylonite with relatively higher yield and higher purity.
[0082] The foregoing description of the embodiments is provided for illustrative purposes and is not intended to limit the scope of this disclosure. Components of a particular embodiment are generally not limited to that particular embodiment and are interchangeable. Such changes should not be considered as departing from this disclosure, and all such modifications are considered to be within the scope of this disclosure.
[0083] The present disclosure is further described in conjunction with the following experiments, which are for illustrative purposes only and should not be construed as limiting the scope of the disclosure. These experiments can be scaled up to industrial / commercial scale, and the results can be extrapolated to industrial scale.
[0084] Experiment Details Example 1: A two-step method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile (Formula I) according to the present disclosure Step (a) – Synthesis of a mixture of compounds of formula III and formula I: A 2-liter four-necked round-bottom flask (RBF) was equipped with a condenser, thermometer sleeve, dropping funnel, and stirrer. At 30°C, with stirring, 200 g of 1-hydroxy-4-(4-tolyl)-3-oxo-1H-imidazol-2-carboxaldehyde oxime (Formula II) and 600 mL of dimethylformamide (DMF) were added to the RBF to obtain a first mixture. At 30°C, with stirring, 250 g of thionyl chloride was added to this mixture; after the addition of thionyl chloride, the mixture was stirred at 30°C for 4 hours to obtain a first product mixture.
[0085] Add 50 mL of water to the first product mixture, and slowly add the resulting product mixture to 2 liters of water. Stir for 2 hours to obtain a solid. Filter the obtained solid, wash with 200 mL of water, and dry to obtain 180 g of a mixture of compound III and compound I in a 50:50 ratio (mixture purity 83%).
[0086] Synthesis of compound (b) – Formula I: A 2-liter four-necked RBF container was equipped with a condenser, thermometer sleeve, dropping funnel, and stirrer. At 30°C, with stirring, 170 g of a mixture of compounds of formula III and I, along with 500 mL of DMF, were added to the RBF to obtain a second mixture. The second mixture was heated at 90°C with stirring, and then 80 g of sodium metabisulfite was added at 90°C with stirring, and stirring was continued at 90°C for 6 hours to obtain a second product mixture.
[0087] Add 50 mL of water to the mixture of the second product to prepare a homogeneous material. Slowly add the resulting homogeneous material dropwise to 2 liters of water and stir for 2 hours to obtain a solid. Filter the solid, wash it with 200 mL of water, purify it with an aqueous acetone solution, and dry it to obtain 120 g of compound I (purity 94%, yield 64.29%).
[0088] Example 2: One-step method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (Formula I) according to the present disclosure A 250 mL four-necked RBF container was equipped with a condenser, thermometer sleeve, dropping funnel, and stirrer. At 30°C, under stirring, 25 g of 1-hydroxy-4-(4-tolyl)-3-oxo-1H-imidazol-2-carboxaldehyde oxime (Formula II) and 75 mL of DMF were added to the RBF to obtain a mixture. At 30°C, under stirring, thionyl chloride was added to this mixture; after the addition of thionyl chloride, the mixture was stirred at 30°C for 4 hours to obtain a reaction mixture. The pH of the reaction mixture was adjusted to neutral by adding 20 mL of triethylamine, and then 7 g of sodium metabisulfite was added at 30°C under stirring. The resulting mixture was then heated to 50°C under stirring for 2 hours to obtain a product mixture.
[0089] Add 20 mL of water to the product mixture, and then slowly add the resulting product mixture to 250 mL of water. Stir for 2 hours to obtain a solid. Filter the obtained solid, wash with 20 mL of water, purify with acetone aqueous solution, and dry to obtain 18 g of compound I (purity 93%, yield 77.15%).
[0090] Comparative example: Comparative Example 1 (Conventional method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile): In the first step, 0.95 mol of 1-hydroxy-4-(4-tolyl)-3-oxo-1H-imidazol-2-carboxaldehyde oxime and 750 mL of N,N-dimethylacetamide were mixed in a 5-liter flask and heated to 100 °C. Sodium metabisulfite (235 g, 1.2 mol) was added in portions to obtain a mixture. This mixture was maintained at 100 °C for 8 hours to obtain a reaction mixture. The mixture was cooled to room temperature and 2000 mL of water was added to precipitate the product. The solid was filtered off, washed with water and toluene, and the washed solid was dried. 139 g of crude (4-tolyl)-1H-imidazol-2-carboxynitrile with a purity of 94.6% was obtained.
[0091] In the second step, 110 g of the product obtained in the first step was mixed with 55 mL of N,N-dimethylacetamide and 55 mL of acetonitrile in a 500 mL flask. 86 g of N-chlorosuccinimide (NCS) was added, maintaining the temperature below 25°C. After the addition was complete, the mixture was stirred at 20°C for 1 hour. The reactants were neutralized with 10% sodium hydroxide and stirred for 1 hour to obtain a crude product mixture. The crude product was filtered, washed with water, re-slurried in toluene, filtered, and then dried in a vacuum oven to obtain 104 g of 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile.
[0092] The schematic process for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxylon according to Comparative Example 2 is shown in Scheme III below: .
[0093] As observed in Example 1 and Comparative Example 1, the method for preparing 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile according to this disclosure is a one-pot method with minimal reagent consumption (catalytic amount only), and the resulting final product 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile has a relatively higher yield and higher purity.
[0094] Furthermore, the reaction conditions of the method disclosed herein are milder compared to the comparative method. Additionally, in the comparative example, chlorination was carried out using N-chlorosuccinimide (NCS). NCS is expensive and produces succinimide byproducts during the reaction. Removal of these byproducts is very troublesome, requiring cumbersome post-treatment.
[0095] Furthermore, in the method disclosed herein, multiple reactions, such as deprotection, dehydration, reduction, and chlorination, occur in one step by using only one reagent (i.e., thionyl chloride), making the method efficient, economical, and environmentally friendly.
[0096] Technological progress The present disclosure described above has several technical advantages, including but not limited to a method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile, the method being: ● Use harmless, inexpensive and readily available raw materials / reagents; ● Requires a relatively short reaction time; ● It produces relatively few impurities; ● Commercially scalable; ● Simple, efficient, cost-effective, and environmentally friendly; and ● It provides 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile with relatively higher purity and higher yield.
[0097] The embodiments described herein, along with their various features and advantages, will be explained with reference to the non-limiting embodiments described below. Descriptions of well-known components and processing techniques have been omitted to avoid unnecessarily obscuring the embodiments described herein. The examples used herein are intended only to facilitate understanding of possible implementations and to further enable those skilled in the art to implement the embodiments described herein. Therefore, these examples should not be construed as limiting the scope of the embodiments described herein.
[0098] The foregoing description of specific embodiments fully reveals the general nature of the embodiments described herein, enabling others to easily modify and / or adjust these specific embodiments for various applications without departing from the general concepts by applying present knowledge; therefore, such modifications and adjustments should and are intended to be understood as being within the meaning and scope of equivalents of the disclosed embodiments. It should be understood that the wording or terminology used herein is for descriptive purposes and not for limitation. Therefore, although the embodiments described herein have been described in conjunction with preferred embodiments, those skilled in the art will recognize that the embodiments described herein can be implemented with modifications within the spirit and scope of the embodiments described herein.
[0099] The use of the terms "at least" or "at least one" means that one or more elements or components or quantities may be used, as such use can achieve one or more intended objectives or results in the embodiments of the invention. While certain embodiments of the invention have been described, these embodiments are presented by way of example only and are not intended to limit the scope of the invention. Those skilled in the art, upon reviewing this disclosure, may make variations or modifications to the concept of the invention within the scope of the invention. Such variations or modifications are entirely within the spirit and scope of the invention.
[0100] Any discussion of documents, actions, materials, devices, articles, etc., included in this specification is for the purpose of providing background to this disclosure only. This should not be construed as an admission that any or all of these matters constitute part of the prior art, or as an admission that they were common general knowledge in the relevant field of this disclosure simply because they existed anywhere prior to the priority date of this application.
[0101] The values given for various physical parameters, dimensions, and quantities are only approximate, and it can be expected that values greater than the specified physical parameters, dimensions, and quantities fall within the scope of this invention, unless otherwise stated in the specification.
[0102] While this document has emphasized the specific features of the preferred embodiments, it should be understood that many additional features can be added and various changes can be made to the preferred embodiments without departing from the principles of this disclosure. These and other changes to the preferred embodiments of this disclosure will be apparent to those skilled in the art based on the disclosure herein, and it should be clearly understood that the foregoing descriptive content should be interpreted as illustrative only and not limiting.
Claims
1. A method for preparing 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (Formula I), the method comprising: The compound of formula II is reacted with a chlorinating agent in a fluid medium, followed by a reaction with a reducing agent, optionally in the presence of a base.
2. The method according to claim 1, wherein the method comprises the following steps: a) In a fluid medium, under stirring, at a first predetermined temperature, the compound of formula II is reacted with a chlorinating agent for a first predetermined time period to obtain a mixture of the compound of formula III and the compound of formula I; and b) In the fluid medium, under stirring and at a second predetermined temperature, a mixture of the compounds of formula III and formula I is reduced using a reducing agent for a second predetermined time period to obtain 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (formula I). 。 3. The method according to claim 1, wherein the method comprises: In a fluid medium, under stirring, at a first predetermined temperature, the compound of formula II is reacted with a chlorinating agent for a first predetermined time period to obtain a reaction mixture; subsequently, the pH of the reaction mixture is adjusted using a base, and then a reducing agent is added and stirred at a second predetermined temperature for a second predetermined time period to obtain 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile (formula I). 。 4. The method according to claims 1 to 3, wherein, The chlorinating agent is thionyl chloride.
5. The method according to claims 1 to 3, wherein, The molar ratio of the compound of formula II to the chlorinating agent is in the range of 1:1.5 to 1:
5.
6. The method according to claims 1 to 3, wherein, The fluid medium is selected from the group consisting of dimethylformamide (DMF), dimethylacetamide, sulfolane, dimethyl sulfoxide, N-methylpyrrolidone, acetonitrile, benzonitrile, and combinations thereof.
7. The method according to claims 2 and 3, wherein, The first predetermined temperature is in the range of 0°C to 60°C.
8. The method according to claims 2 and 3, wherein, The first predetermined time period is in the range of 2 to 10 hours.
9. The method according to claim 3, wherein, The alkali is selected from organic alkalis and inorganic alkalis.
10. The method according to claim 9, wherein: ● The organic base is selected from the group consisting of triethylamine, diisopropylamine, pyridine, piperidine, and morpholine; ● The inorganic base is selected from the group consisting of ammonia, potassium carbonate, sodium carbonate, potassium hydroxide, and sodium hydroxide.
11. The method according to claims 1 to 3, wherein, The reducing agent is selected from the group consisting of metal salts containing sulfur derivatives, sodium metabisulfite, sodium bisulfite, sodium sulfite, potassium bisulfite, potassium metabisulfite, potassium sulfite, potassium dithionite, sodium dithionite, and combinations thereof.
12. The method according to claim 3, wherein, The molar ratio of the compound of formula II to the reducing agent is in the range of 1:0.1 to 1:
1.
13. The method according to claim 3, wherein, The molar ratio of the compound of formula II to the base is in the range of 1:1 to 1:
3.
14. The method according to claim 2, wherein, The second predetermined temperature is in the range of 40°C to 150°C.
15. The method according to claim 2, wherein, The second predetermined time period is in the range of 1 hour to 15 hours.
16. The method according to claim 1, wherein, The yield of the 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile is in the range of 60% to 80%.
17. 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxynitrile prepared by the method according to any one of claims 1 to 16.
18. The 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxylon according to claim 17, wherein the purity of the 4-chloro-5-(4-tolyl)-1H-imidazol-2-carboxylon is greater than 90%.
19. The 4-chloro-5-(4-tolyl)-1H-imidazolium-2-carboxynitrile according to claim 18, wherein the purity is in the range of 90% to 96%.
